교육


교수진 소개

Home > 교육 > 교수진 소개

SokbomKang

Name
Kang, Sok Bom, M.D., Ph.D.(adjunct professor)
Faculty Appointment
(title, department)
Professor, Department of Cancer Control and Population Health, NCC-GCSP
Area of Expertise
 
Contact no
+82-31-920-2382
E-mail
sokbom@gmail.com
Previous Appointment(s) Held
Educational Background
Research Interests (Please place in paragraph form)
International Collaboration
2019 Comparison of CA 125 alone and risk of ovarian malignancy algorithm (ROMA) in patients with adnexal mass: A multicenter study: Current Problems in Cancer. : (3.698)

2019 SCI-E Phase I/II clinical trial of modulated electro-hyperthermia treatment in patients with relapsed, refractory or progressive heavily treated ovarian cancer: JAPANESE JOURNAL OF CLINICAL ONCOLOGY. Online:Published (2.183)

2019 SCI Real-world effectiveness of bevacizumab based on AURELIA in platinum-resistant recurrent ovarian cancer (REBECA): A Korean Gynecologic Oncology Group study (KGOG 3041): GYNECOLOGIC ONCOLOGY. 152(1):61~67 (4.54)

2018 SCI Second primary colorectal cancer among endometrial cancer survivor: shared etiology and treatment sequelae: Journal of cancer research and clinical oncology. 144(5):845~854 (3.282)

2017 SCI-E Role of preoperative magnetic resonance imaging and histologic assessment in identifying patients with a low risk of endometrial cancer: a Korean Gynecologic Oncology Group ancillary study: Oncotarget. 8(62):106009~106016 (5.168)

2017 SCI-E Comparing prediction models forlymph node metastasis risk inendometrial cancer: the winner maynot take it all: journal of gynecologic oncology. 28:e92~e92 (3.14)

2017 SCI-E Phase I study of oral ridaforolimus in combination with paclitaxel and carboplatin in patients with solid tumor cancers: BMC cancer. 17:407~407 (3.288)

2017 SCI-E Survival outcomes after extensive cytoreductive surgery and selective neoadjuvant chemotherapy according to institutional criteria in bulky stage IIIC and IV epithelial ovarian cancer: Journal of Gynecologic Oncology. 28(4):e48~e48 (3.14)

2017 SCI-E Do we need a better marker for successful ovarian cancer surgery?: Journal of Gynecologic Oncology. 28(1):e21~e21 (3.14)

2016 SCI Preoperative assessment of lymph node metastasis in endometrial cancer: A Korean Gynecologic Oncology Group study: Cancer. 123(2):263~272 (5.649)

2016 SCI Prophylactic irradiation of para-aortic lymph nodes for patients with locally advanced cervical cancers with and without high CA9 expression (KROG 07-01): A randomized, open-label, multicenter, phase 2 trial: Radiotherapy and Oncology. 120(3):383~389 (4.817)

2016 SCI-E Health Behaviors and Associated Sociodemographic Factors in Cervical Cancer Survivors Compared with Matched Non-Cancer Controls.: PLoS One. 11(8):e0160682~e0160682 (3.057)

2016 SCI Predictors of Radiation Field Failure After Definitive Chemoradiation in Patients With Locally Advanced Cervical Cancer: International Journal of Gynecological Cancer. 26(4):737~742 (2.116)

2016 SCI-E Population attributable risks of modifiable reproductive factors for breast and ovarian cancers in Korea: BMC Cancer. 16:5~5 (3.265)

2015 SCI-E Second Primary Cancer after Diagnosis and Treatment of Cervical Cancer: Cancer research and treatment. 48(2):641~649 (3.318)

2015 SCI Postoperative Lower Extremity Edema in Patients with Primary Endometrial Cancer: Annals of surgical oncology. 23(1):186~195 (3.93)

2015 SCI Comparison of Lower Extremity Edema in Locally Advanced Cervical Cancer: Pretreatment Laparoscopic Surgical Staging with Tailored Radiotherapy Versus Primary Radiotherapy.: Annals of surgical oncology. 23(1):203~210 (3.93)

2015 SCI Uptake of risk-reducing salpingo-oophorectomy among female BRCA mutation carriers: experience at the National Cancer Center of Korea.: Journal of Cancer Research and Clinical Oncology. 142(1):333~340 (3.081)

2015 SCI Impact of lower limb lymphedema on quality of life in gynecologic cancer survivors after pelvic lymph node dissection: European journal of obstetrics, gynecology, and reproductive biology. 192:31~36 (1.695)

2015 SCI-E Multi-dimensional TOF-SIMS analysis for effective profiling of disease-related ions from the tissue surface.: Scientific reports.. 5:11077~11085 (5.578)

2015 SCI-E Incidental cholecystectomy in patients with asymptomatic gallstones undergoing surgery for colorectal cancer.: Digestive surgery. 32(3):183~189 (2.162)

2015 SCI-E Ligation of uterine vessels in total laparoscopic hysterectomy using Hem-o-lok clips.: Taiwanese journal of obstetrics & gynecology. 54(1):8~12 (0.988)

2015 SCI-E Survival outcome in endometrial cancer patients according to hereditary predisposition: Taiwanese journal of obstetrics & gynecology. 54(1):24~28 (0.988)

2015 SCI Benefit of Negative Pressure Drain Within Surgical Wound After Cytoreductive Surgery for Ovarian Cancer: International jouranl of gynecological cancer. 25(1):145~151 (1.958)

2014 SCI The cost-effectiveness of selective lymphadenectomy based on a preoperative prediction model in patients with endometrial cancer: Insights from the US and Korean healthcare systems: Gynecologic Oncology. 135(3):518~524 (3.687)

2014 SCI Low Expression of miR-449 in Gynecologic Clear Cell Carcinoma: International journal of gynecological cancer. 24(9):1558~1563 (1.949)

2014 SCI Gynecologic Cancer InterGroup (GCIG) Consensus Review for Clear Cell Carcinoma of the Ovary: International journal of gynecological cancer. 24(9-3):s20~s25 (1.949)

2014 기타 The antihypertension drug doxazosin suppresses JAK/STATs phosphorylation and enhances the effects of IFN-α/γ-induced apoptosis: Genes and Cancer. 5 (11-12):470~479 (0)

2014 SCI Lymph Node Status Did Not Significantly Improve the Predictability of Survival in Patients With Clinically Early-Stage Endometrial Cancer: International journal of gynecological cancer. 24(8):1449~1454 (1.949)

2014 SCI-E Completeness of pedigree and family cancer history for ovarian cancer patients: Journal of gynecologic oncology. 25(4):342~348 (1.6)

2014 SCI-E Thioridazine inhibits angiogenesis and tumor growth by targeting the VEGFR-2/PI3K/mTOR pathway in ovarian cancer xenografts: Oncotarget. 5(13):4929~4934 (6.627)

2014 SCI-E Major clinical research advances in gynecologic cancer in 2013: Journal of gynecologic oncology. 25(3):236~248 (1.6)

2014 SCI Development and evaluation of the Korean version of the Gynecologic Cancer Lymphedema Questionnaire in gynecologic cancer survivors: Gynecologic Oncology. 133(1):111~116 (3.687)

2014 SCI-E Lower extremity edema in patients with early ovarian cancer: Journal of ovarian research. 7(1):28~28 (2.03)

2014 SCI A Web-Based Nomogram Predicting Para-aortic Nodal Metastasis in Incompletely Staged Patients With Endometrial Cancer: A Korean Multicenter Study: International journal of gynecological cancer. 24(3):513~519 (1.949)

2014 SCI Application of a subcutaneous negative pressure drain without subcutaneous suture: impact on wound healing in gynecologic surgery: European journal of obstetrics & gynecology and reproductive biology. 173:94~100 (1.627)

2014 SCI-E Tailoring lymphadenectomy according to the risk of lymph node metastasis in endometrial cancer: Journal Of Obstetrics & Gynaecology Research. 40(2):317~21 (0.931)

2014 SCI-E Proposal of a concept and design of a randomized phase III trial investigating the survival effect of para-aortic lymphadenectomy in endometrial cancer: The journal of obstetrics and gynaecology research. 40(2):312~316 (0.931)

2014 SCI-E Risk assessment of lymph node metastasis before surgery in endometrial cancer: do we need a clinical trial for low-risk patients?: The journal of obstetrics and gynaecology research. 40(2):322~326 (0.931)

2013 Use of complex surgical procedures, patterns of tumor spread, and CA-125 predicts a risk of incomplete cytoreduction: a Korean Gynecologic Oncology Group study (KGOG-3022): Gynecologic oncology. 131(2):336~340 (3.929)

2013 SCI Clinical significance of tumor volume in endometrial cancer: a Japan-Korea cooperative study: Gynecologic Oncology. 131(2):294~298 (3.929)

2013 SCI-E Incidence of cervical, endometrial, and ovarian cancer in Korea, 1999-2010.: Journal of Gynecologic Oncology. 24(4):298~302 (1.73)

2013 기타 Cost-utility analysis for platinum-sensitive recurrent ovarian cancer therapy in South Korea: results of the polyethylene glycolated liposomal doxorubicin/carboplatin sequencing model.: ClinicoEconomics and outcomes research. 5:297~307 (0)

2013 SCI Discrepancy Between Preoperative Imaging and Surgical Findings in Patients With Advanced Ovarian Cancer: A Study of Initial False-Negative Lesions: Journal of Computer Assisted Tomography. 37(4):568~571 (1.582)

2013 SCI The size of the metastatic lymph node is an independent prognostic factor for the patients with cervical cancer treated by definitive radiotherapy: Radiotherapy and Oncology. 1081(1):168~173 (4.52)

2013 SCI-E Practice guidelines for the early detection of cervical cancer in Korea: Korean Society of Gynecologic Oncology and the Korean Society for Cytopathology 2012 edition: Journal of Gynecologic Oncology. 24(2):186~203 (1.73)

2013 SCI A low-risk group for lymph node metastasis is accurately identified by Korean gynecologic oncology group criteria in two Japanese cohorts with endometrial cancer: Gynecologic oncology. 129(1):33~37 (3.929)

2013 SCI-E High Control Rate for Lymph Nodes in Cervical Cancer Treated with High-dose Radiotherapy using Helical Tomotherapy: Technology in Cancer Research and Treatment. 12(1):45~51 (1.943)

2013 SCI-E Coexisting carcinoma in endometrial hyperplasia: does more risk factor mean better discrimination?: Journal of Gynecologic Oncology. 24(1):1~2 (1.73)

2013 SCI-E Brain metastasis in patients with uterine cervical cancer: Journal of Obstetrics and Gynaecology Research. 39(1):287~291 (0.841)

2012 SCI-E Phase II study of paclitaxel in combination with carboplatin for patients with recurrent or persistent uterine sarcoma.: Archives of gynecology and obstetrics.. 286(6):1529~1535 (1.277)

2012 SCI-E Urologic complications of laparoscopic radical hysterectomy and lymphadenectomy: International urogynecology journal. 23(11):1605~1611 (1.832)

2012 SCI Anti-angiogenic effects of thioridazine involving the FAK-mTOR pathway: Microvascular Research. 84(3):227~234 (2.828)

2012 SCI-E Pelvic exenteration for recurrent cervical cancer: ten-year experience at National Cancer Center in Korea: Journal of Gynecology Oncology. 23(4):242~250 (1.489)

2012 SCI Thioridazine induces apoptosis by targeting the PI3K/Akt/mTOR pathway in cervical and endometrial cancer cells.: Apoptosis. 17(9):989~997 (4.788)

2012 SCI Risk Assessment Tool for Distant Recurrence After Platinum-Based Concurrent Chemoradiation in Patients With Locally Advanced Cervical Cancer: A Korean Gynecologic Oncology Group Study.: Journal of Clinical Oncology. 30(19):2369~2374 (18.372)

2012 기타 Intraoperative image-guided surgery for ovarian cancer: Quantitative imaging in medicine and surgery. 3:114~117 (0)

2012 SCI Association between the location of transposed ovary and ovarian function in patients with uterine cervical cancer treated with (postoperative or primary) pelvic radiotherapy.: Fertility and sterility.. 97(6):1387~1393 (3.775)

2012 SCI Serum HE4 Level is an Independent Prognostic Factor in Epithelial Ovarian Cancer: Annals of Surgical Oncology. 19(5):1707~1712 (4.166)

2012 SCI Preoperative identification of a low-risk group for lymph node metastasis in endometrial cancer: a Korean gynecologic oncology group study: Journal of Clinical Oncology. 30(12):1329~1334 (18.372)

2012 SCI-E Performance of Papanicolaou Testing and Detection of Cervical Carcinoma In Situ in Participants of Organized Cervical Cancer Screening in South Korea: PLoS ONE. 7(4):e35469~e35469 (4.092)

2012 SCI Correlation Between Body Mass Index and Prevalence of Hereditary Nonpolyposis Colorectal Cancer in Korean Patients With Endometrial Cancer: International Journal of Gynecological Cancer. 22(2):267~272 (1.646)

2012 SCI Management of the Elderly Patient With Gynecologic Cancer: Report of the 2011 Workshop in Geriatric Gynecologic Oncology.: International Journal of Gynecological Cancer. 22(1):161~169 (1.646)

2011 SCI-E Outcomes and toxicities for the treatment of stage IVB cervical cancer: Archives of gynecology and obstetrics. 285(6):1685~1693 (1.277)

2011 SCI Phase I clinical trial of alternating belotecan and oral etoposide in patients with platinum-resistant or heavily treated ovarian cancer.: Anticancer drugs. Online:Published (2.376)

2011 SCI Alteration in lipid and protein profiles of ovarian cancer: similarity to breast cancer.: International Journal of Gynecological Cancer. 21(9):1566~1572 (1.558)

2011 SCI Is Neo-adjuvant Chemotherapy a "Waiver" of Extensive Upper Abdominal Surgery in Advanced Epithelial Ovarian Cancer?: Annals of Surgical Oncology. 18(13):3824~3827 (4.182)

2011 SCI Sentinel lymph node biopsy in endometrial cancer: Meta-analysis of 26 studies.: Gynecologic oncology. 123(3):522~527 (3.76)

2011 SCI Persistent human papillomavirus DNA is associated with local recurrence after radiotherapy of uterine cervical cancer: International Journal of Cancer. 129(4):896~902 (4.926)

2011 SCI-E Phase II study of belotecan (CKD 602) as a single agent in patients with recurrent or progressive carcinoma of uterine cervix: JAPANESE JOURNAL OF CLINICAL ONCOLOGY. 41(5):624~629 (1.856)

2011 SCI Cyclooxygenase-2 is an independent predictor of poor prognosis in uterine leiomyosarcomas: Int J Gynecol Cancer. 21:668~672 (1.558)

2011 SCI Extended Cytoreduction of Tumor at the Porta Hepatis by an Interdisciplinary Team Approach in Patients with Epithelial Ovarian Cancer: Gynecologic Oncology. 121(2):253~257 (3.76)

2011 SCI-E Cervical adenocarcinoma in situ with negative conization margin: negligible or not?: Journal of gynecologic oncology. 22(1):1~2 (0)

2011 SCI Role of Extended Chemotherapy in Advanced Ovarian Cancer Patients with High Posttreatment Serum CA-125 Levels.: GYNECOLOGIC AND OBSTETRIC INVESTIGATION. 72(1):50~54 (1.031)

2011 SCI Pelvic Lymph Node Status Assessed by 18f-Fluorodeoxyglucose Positron Emission Tomography Predicts Low-Risk Group for Distant Recurrence in Locally Advanced Cervical Cancer: A Prospective Study.: International journal of radiation oncology, biology, physics. 79(3):788~793 (4.503)

2011 SCI-E Region-based Diagnostic Performance of Multi-detector CT for Detecting Peritoneal Seeding in Ovarian Cancer Patients: Archives of Gynecology and Obstetrics. 283(2):353~360 (1.072)

2011 SCI Anti-apoptotic protein TCTP controls the stability of the tumor suppressor p53: FEBS Letters. 585:29~35 (3.601)

2011 SCI A gene signature-based approach identifies thioridazine as an inhibitor of phosphatidylinositol-3'-kinase (PI3K)/AKT pathway: Gynecologic Oncology. 120(1):121~127 (3.76)

2011 SCI Interaction between preoperative CA-125 level and survival benefit of neoadjuvant chemotherapy in advanced epithelial ovarian cancer: Gynecologic Oncology. 120(1):18~22 (3.76)

2010 SCI-E Epidemiological characteristics of ovarian cancer in Korea: Journal of Gynecologic Oncology. 21:241~247 ()

2010 SCI Identification of a patient group at low risk for parametrial invasion in early-stage cervical cancer.: Gynecologic oncology. 119(3):426~430 (3.733)

2010 SCI-E Hereditary Non-polyposis Colorectal Cancer/Lynch Syndrome in Korean Patients with Endometrial Cancer: Japanese Journal of Clinical Oncology. 40(12):1121~1127 (1.498)

2010 SCI Preoperative prediction model of lymph node metastasis in endometrial cancer.: International Journal of Gynecological Cancer. 20(8):1350~1355 (2.179)

2010 SCI Frequent promoter hypermethylation of TGFBI in epithelial ovarian cancer: Gynecologic Oncology. 118:58~63 (3.733)

2010 SCI Feasibility and Safety of Extensive Upper Abdominal Surgery in Elderly Patients with Advanced Epithelial Ovarian Cancer: Journal of Korean Medical Science. 25(7):1034~1040 (0.838)

2010 SCI Residual cancer stem cells after interval cytoreductive surgery following neoadjuvant chemotherapy could result in poor treatment outcomes for ovarian cancer: Onkologies. 33(6):324~330 (1.234)

2010 SCI-E Lower urinary tract injuries diagnosed after hysterectomy: Seven-year experience at a cancer hospital: The Journal Of Obstetrics and Gynaecology Research. 36:318~325 (0.777)

2010 SCI Diagnostic Value of 18F-FDG PET for Evaluation of Paraaortic Nodal Metastasis in Patients with Cervical Carcinoma: A Metaanalysis.: Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 51(3):360~367 (6.424)

2010 SCI-E Comparison of the efficacy between topotecan- and belotecan-, a new camptothecin analog, based chemotherapies for recurrent epithelial ovarian cancer: a single institutional experience: The journal of obstetrics and gynaecology research. 36(1):86~93 (0.777)

2010 SCI Multidetector CT predictors of incomplete resection in primary cytoreduction of patients with advanced ovarian cancer: European Radiology. 20:100~107 (3.589)

2010 SCI Preoperative serum CA-125 levels and risk of suboptimal cytoreduction in ovarian cancer: A meta-analysis.: Journal of Surgical Oncology. 101(1):13~17 (2.502)

2009 SCI-E The utility of multi-detector computed tomography in the diagnosis of malignant pleural effusion in the patients with ovarian cancer: European Journal of Radiology. 75(2):230~235 (2.645)

2009 SCI-E Minimizing tumor burden by extensive cytoreductive surgery decreases postoperative venous thromboembolism in ovarian clear cell carcinoma: Archives of Gynecology and Obstetrics. 281(2):329~334 (0.912)

2009 SCI BRCA1 and BRCA2 Germline Mutations in Korean Ovarian Cancer Patients: Journal of Cancer Research and Clinical Oncology. 153(11):1593~1599 (2.217)

2009 SCI Embryonic natural orifice transumbilical endoscopic surgery (E-NOTES) for adnexal tumors: Surgical Endoscopy. 23(11):2445~2449 (3.231)

2009 SCI Natural history of persistent high-risk human papillomavirus infections in Korean women: Gynecologic Oncology. 115(1):75~80 (2.919)

2009 SCI Nadir CA-125 level is an independent prognostic factor in advanced epithelial ovarian cancer: Journal of Surgical Oncology. 100(3):244~247 (2.478)

2009 SCI Total colectomy as part of primary cytoreductive surgery in advanced mullerian cancer: Gynecologic Oncology. 114(2):183~187 (2.919)

2009 SCI Does Neoadjuvant Chemotherapy Increase Optimal Cytoreduction Rate in Advanced Ovarian Cancer? Meta-Analysis of 21 Studies: Annals of Surgical Oncology. 16(8):2315~2320 (3.898)

2009 SCI-E Clinical manifestations in patients with ovarian clear cell carcinoma with or without co-existing endometriosis: Gynecological Endocrinology. 25(7):435~440 (1.359)

2009 SCI-E Prognostic factors of secondary cytoreductive surgery for patients with recurrent epithelial ovarian cancer: Journal of Gynecologic Oncology. 20(2):101~106 ()

2009 SCI-E Role of high risk-human papilloma virus test in the follow-up of patients who underwent conization of the cervix for cervical intraepithelial neoplasia: Journal of Gynecologic Oncology. 20(2):86~90 (0)

2009 SCI Hyperthermic Intraperitoneal Chemotherapy Following Extensive Cytoreductive Surgery in Patients with Primary Advanced Epithelial Ovarian Cancer: Interim Analysis of a Phase II Study: Annals of Surgical Oncology. 16(4):993~1000 (3.898)

2009 SCI Cross-cultural application of the Korean version of the European Organization for Research and Treatment of Cancer (EORTC) Quality-of-Life Questionnaire Cervical Cancer Module: Oncology. 76(3):190~198 (1.336)

2008 SCI The clinical significance of hepatic parenchymal metastasis in patients with primary epithelial ovarian cancer.: Gynecologic Oncology. 112(1):28~34 (2.614)

2008 SCI Laparoscopic and laparotomic staging in stage I epithelial ovarian cancer: a comparison of feasibility and safety: International Journal of Gynecological Cancer. Online:Published (1.425)

2008 SCI Insulin-like growth factor binding protein-5 (IGFBP-5) acts as a tumor suppressor by inhibiting angiogenesis: Carcinogenesis. 29:2106~2111 (5.406)

2008 SCI Occult para-aortic lymph node metastasis after negative positron emission tomography/computed tomography scan: Journal of Clinical Oncology. 26(31):5140~5140 (15.5)

2008 SCI-E Unusual 2-[18F]-fluoro-2-deoxy-D: -glucose accumulation induced by postoperative intestinocutaneous fistula in the patient with uterine cervical cancer and SLE.: Archives of Gynecology and Obstetrics. Online:Published (0.666)

2008 SCI Safety and immunogenicity of a vaccine targeting human papillomavirus types 6, 11, 16 and 18: a randomized, placebo-controlled trial in 176 Korean subjects: International Journal of Gynecological Cancer. 18:1013~1019 (1.425)

2008 SCI The validity of tumour diameter assessed by magnetic resonance imaging and gross specimen with regard to tumour volume in cervical cancer patients: European Journal of Cancer. 44:1524~1528 (4.454)

2008 SCI The association of pre-conization high-risk HPV load and the persistence of HPV infection and persistence/recurrence of cervical intraepithelial neoplasia after conization: Gynecologic Oncology. 108:549~554 (2.614)

2008 SCI Mutual exclusiveness between PIK3CA and KRAS mutations in endometrial carcinoma.: International Journal of Gynecological Cancer(상위20#이내 학술지 아님). Online:Published (1.425)

2008 SCI FAS -1377 G/A polymorphism and the risk of lymph node metastasis in cervical cancer: Cancer Genetics and Cytogenetics. 180:1~5 (1.559)

2007 SCI Epidermal growth factor 61 A/G polymorphism and uterine cervical cancer: International Journal of Gynecological Cancer. 17:492~496 (1.428)

2007 SCI Hypermethylation of the COX-2 gene is a potential prognostic marker for cervical cancer: JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH. 33(3):236~41 (0.83)

2007 SCI Port-site and liver metastases after laparoscopic pelvic and para-aortic lymph node dissection for surgical staging of locally advanced cervical cancer cancer: International Journal of Gynecological Cancer. 18:176~180 (1.425)

2007 기타 The Effect of Tibolone on Bone Density in Women with Early Menopause Resulting from Cancer Treatment: Journal of the Korean society of osteoporosis. 5:72~77 (0)

2007 SCI The clinical values of squamous cell carcinoma antigen and carcinoembryonic antigen in patients with cervical cancer treated with concurrent chemoradiotherapy: International Journal of Gynecologic Cancer. 17:872~878 (1.469)

2007 SCI Risk factors predicting residual disease in subsequent hysterectomy following conization for cervical intraepithelial neoplasia (CIN) III and microinvasive cervical cancer.: Gynecol Oncol.. Online:Published (2.319)

2007 SCI Inverse correlation between RASSF1A hypermethylation, KRAS and BRAF mutations in cervical adenocarcinoma: Gynecologic Oncology(상위20#이내 학술지 아님). 105:662~666 (2.319)

2007 SCI The C19007T Polymorphism of ERCC1 and Its Correlation with the Risk of Epithelial Ovarian and Endometrial Cancer in Korean Women. A Case Control Study.: Gynecologic and obstetric investigation. 64:84~88 (0.874)

2007 SCI Interleukin-1 beta-511 polymorphism and risk of cervical cancer: Journal of Korean Medical Science. 22:110~113 (0.824)

2006 SCI The benefits of low anterior en bloc resection as part of cytoreductive surgery for advanced primary and recurrent epithelial ovarian cancer patients outweigh morbidity concerns: Gynecologic Oncology. 103:977~984 (2.251)

2006 SCI CT findings of clear cell carcinoma of the ovary: Journal of Computer Assisted Tomography. 30:875~879 (1.369)

2006 SCI MRI for pretreatment lymph node staging in uterine cervical cancer: American Journal of Roentgenology. 187:538~543 (2.209)

2006 SCI Contrast-enhanced CT for differentiation of ovarian metastasis from gastrointestinal tract cancer: stomach cancer versus colon cancer.: American journal of roentgenology. 187:741~745 (2.209)

2006 SCI RASSF1A hypermethylation and its inverse correlation with BRAF and/or KRAS mutations in MSI-associated endometrial carcinoma: International Journal of Cancer. 119:1316~1321 (4.7)

2006 SCI Association between excision repair cross-complementation group 1 polymorphism and clinical outcome of platinum-based chemotherapy in patients with epithelial ovarian cancer: Experimental and Molecular Medicine. 38:320~324 (2.296)

2006 SCI Elevation of cyclooxygenase-2 is related to lymph node metastasis in adenocarcinoma of uterine cervix: Cancer Letters. 239:198~204 (3.277)

2006 SCI Comparison of DNA hypermethylation patterns in different types of uterine cancer: Cervical squamous cell carcinoma, cervical adenocarcinoma and endometrial adenocarcinoma: International journal of cancer. 118:2168~2171 (4.7)

2005 SCI Polymorphism in the nuclear factor kappa-B binding promoter region of cyclooxygenase-2 is associated with an increased risk of bladder cancer: Cancer Letter. 217:11~6 (3.398)

2005 SCI Polymorphism in the E6 gene of human papillomavirus type 16 in the cervical tissues of Korean women: International Journal of Gynecological Cancer. 15:107~12 (1.548)

2005 SCI Feasibility of radical surgery in the management of elderly patients with uterine cervical cancer in Korea: GYNECOLOGIC AND OBSTETRIC INVESTIGATION. 59:165~70 (1.15)

2005 SCI Promoter polymorphism in the matrix metalloproteinase-1 and risk of cervical cancer in Korean women: Cancer Letter. 217:191~6 (3.398)

2005 SCI Polymorphism in folate- and methionine-metabolizing enzyme and aberrant CpG island hypermethylation in uterine cervical cancer: Gynecologic Oncology. 96:173~80 (2.614)

2005 SCI Cyclin D1 polymorphism and the risk of endometrial cancer: Gynecologic Oncology. 97:431~5 (2.61)

2004 SCI Cyclooxygenase-2 and p53 expressions in endometrial cancer: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 13:1538~42 (4.642)

list

top